🇺🇸 FDA
Patent

US 7563795

Phenyl-piperazine derivatives as modulators of muscarinic receptors

granted A61KA61K31/495A61K31/496

Quick answer

US patent 7563795 (Phenyl-piperazine derivatives as modulators of muscarinic receptors) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/495, A61K31/496, A61P, A61P1/00